In this issue:
– Recurrence after anticoagulation discontinuation in COVID-19-associated VTE
– Molecular revolution in haemophilia treatment
– Lifetime risks of complications in obstetric APS
– Efanesoctocog alfa prophylaxis for paediatric severe haemophilia A
– Iron, haemochromatosis genotypes and infection risk
– Fitusiran prophylaxis for haemophilia after bypassing agent/clotting factor
– Cytoreductive therapy in younger adults with polycythaemia vera
– Thrombotic events with FVIII products and emicizumab
– Genetic basis of pregnancy associated thrombocytopenia
– Aspirin vs. LMWH after orthopaedic surgery
Expert contributor
Paul Ockelford is a recently retired haematologist and former director of both the Adult Haemophilia Centre and Thrombosis Unit at Auckland City Hospital. Paul has particular expertise in haemostasis and thrombosis and consults on a wide range of haematological disorders. He maintains an active research programme in the treatment of venous thromboembolism. Paul is a […]
Expert contributor
Laura is a haematologist specialising in thrombosis and haemostasis. Having trained at the University of Auckland, School of Medicine, she completed her training in haematology in Auckland, and then completed a period of research at the University of Auckland as part of a PhD focusing on coagulation inhibitors. She is now employed at Auckland Hospital […]
Stay up to date with our latest clinical information.
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.